Capture

List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic

  • To improve transparency and encourage the development and submission of  ANDAs in markets with limited competition
  • Part I of the list identifies those drug products for which FDA could immediately accept an ANDA without prior discussion
  • Part II identifies drug products for which ANDA development or approval may raise potential legal, regulatory, or scientific issues that should be addressed with the Agency prior to considering submission of an ANDA

LEARN


Image credit: FDA


Leave a Reply


Fill in your details below or click an icon to log in:

WordPress.com Logo



You are commenting using your WordPress.com account.
Log Out / 
Change )

Google photo



You are commenting using your Google account.
Log Out / 
Change )

Twitter picture



You are commenting using your Twitter account.
Log Out / 
Change )

Facebook photo



You are commenting using your Facebook account.
Log Out / 
Change )

Connecting to %s